<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="165264">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00946452</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-RMY-SYM-2009/1</org_study_id>
    <nct_id>NCT00946452</nct_id>
  </id_info>
  <brief_title>Symbicort SMART Satisfaction From Patient Perspective 2009</brief_title>
  <official_title>Symbicort SMART Satisfaction From Patient Perspective 2009</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To characterize the level of asthma control and patient satisfaction amongst diagnosed
      asthma sufferers who are currently receiving Symbicort Maintenance and Reliever Therapy
      (SMART) in Malaysia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Score level of Satisfaction in Asthma Treatment Questionnaire (SATQ)</measure>
    <time_frame>After 3 months on SMART - once</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Score level of Asthma Control Test (ACT)</measure>
    <time_frame>After 3 months on SMART - once</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">205</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have been prescribed Symbicort SMART (1 or 2 inhalation twice daily) by their Dr's
             for the past 3 months

          -  Informed consent

        Exclusion Criteria:

          -  Symbicort SMART treatment &lt; 3 months

          -  Patients requiring short courses of oral steroids more than twice in a month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liam Chong Kin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Petaling Jaya</city>
        <state>Selangor</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <lastchanged_date>March 17, 2010</lastchanged_date>
  <firstreceived_date>July 24, 2009</firstreceived_date>
  <responsible_party>
    <name_title>MC MD</name_title>
    <organization>AstraZeneca Pharmaceuticals</organization>
  </responsible_party>
  <keyword>Control</keyword>
  <keyword>Satisfaction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
